This is the authors' abstract. We don't add key points for this paper.
Interactions between food-derived angiotensin-I-converting enzyme (ACE)-inhibitory peptides and polyphenols may influence multicomponent inhibitor performance. Enzymatic assays and Chou-Talalay combination index analysis evaluated leucyl-alanyl-phenylalanine (LAF), leucyl-leucyl-leucine (LLL), quercetin (QU), chlorogenic acid (CA), epigallocatechin gallate (EGCG), and their mixtures at five peptide-to-polyphenol molar ratios. EGCG-containing mixtures showed synergistic inhibition, with mean CI values of 0.89 and 0.81 for LAF-EGCG and LLL-EGCG, respectively, whereas LAF-QU and LLL-QU were antagonistic (mean CI: 1.51 and 1.19). LAF-CA and LLL-CA showed mean CI values of 0.81 and 0.72, respectively, although these values remain provisional due to the limited characterization of CA’s individual dose–effect relationship. Simulations associated CA- and EGCG-containing systems with persistent peptide contacts, more compact active-pocket conformations, and higher calculated peptide-dissociation barriers; QU-containing systems showed greater pocket overlap and lower barriers. These in vitro and computational results provide a target-level framework for prioritizing peptide-polyphenol pairs for further food-matrix, digestion, transport, and in vivo validation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: